The moderate growth of the global breast biopsy device market will be driven primarily by the increasing awareness of breast cancer screening in developing markets like China and India, the ongoing shift toward CNB devices in rural areas across different geographies, and the shift toward premium-priced VAB devices in urban areas of developed markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the breast biopsy device market in the US, Europe, and Asia Pacific region across a 10-year period.


Moderate procedure growth will occur in the Asia Pacific region due to greater disease awareness and increasing screening participation in the emerging markets of China and India.

How many procedures are performed annually in these two countries?

Among VAB, CNB, and FNA, which procedure type has the highest penetration in each of these countries?

VAB will continue to be the most common technique for performing breast biopsies in the US, driving global market growth.

How quickly are VAB procedure volumes growing in the US?

To what extent is VAB being used in Europe and the Asia Pacific region?

Breast biopsy markers represent a significant proportion of overall market revenues.

What factors impact the use of breast biopsy markers?

Will the ASP of breast biopsy markers decline over the forecast period?

Table of contents

  • Global
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Breast Biopsy Device Market
      • Market Highlights
        • US
        • Europe
        • Asia Pacific
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Landscape
      • Market Developments
      • Market Share Rankings
    • Vacuum-Assisted Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Landscape
      • Major Competitors in the Vacuum-Assisted Biopsy Device Market
    • Core Needle Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Major Competitors in the Core Needle Biopsy Device Market
    • Fine Needle Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Major Competitors in the Fine Needle Market
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Sanketh Kamath, MBA

Sanketh Kamath is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in urology, gynecology, diagnostic imaging systems, drug delivery devices, and medical device outsourcing. He has also worked on procedure claims code alignment for DRG's US Procedure Finder product. Sanketh holds an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, India. Follow Sanketh on twitter: @ksankethb_DRG


Related Reports

Biopsy Devices | Medtech 360 | Market Insights | Europe

The European biopsy device market will continue to grow modestly through 2028, driven largely by growth in the percutaneous soft tissue biopsy...

View Details

Biopsy Devices | Medtech 360 | Market Insights | United States

Biopsy procedure volumes will continue to grow at a modest rate through 2028, driven by favorable demographic trends, the development of more accurate testing methods,...

View Details

Biopsy Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for biopsy devices will be driven primarily by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increa...

View Details